Detalles de la búsqueda
1.
Bortezomib and Vorinostat Therapy as Maintenance Therapy Post Autologous Transplant for Non-Hodgkin's Lymphoma Using R-BEAM or BEAM Transplant Conditioning Regimen.
Acta Haematol;
2023 Sep 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-37708877
2.
Diagnosis and Management of Multiple Myeloma: A Review.
JAMA;
327(5): 464-477, 2022 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35103762
3.
A single-center retrospective analysis of outcome measures and consolidation strategies for relapsed and refractory primary CNS lymphoma.
J Neurooncol;
151(2): 193-200, 2021 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-33398532
4.
Survivorship after Autologous Hematopoietic Cell Transplantation for Lymphoma and Multiple Myeloma: Late Effects and Quality of Life.
Biol Blood Marrow Transplant;
26(2): 407-412, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31605822
5.
A phase II trial evaluating the efficacy of high-dose Radioiodinated Tositumomab (Anti-CD20) antibody, etoposide and cyclophosphamide followed by autologous transplantation, for high-risk relapsed or refractory non-hodgkin lymphoma.
Am J Hematol;
95(7): 775-783, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32243637
6.
Bortezomib and Vorinostat Therapy as Maintenance Therapy after Autologous Transplant for Multiple Myeloma.
Acta Haematol;
143(2): 146-154, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-31434076
7.
Effect of Conditioning Regimen Dose Reduction in Obese Patients Undergoing Autologous Hematopoietic Cell Transplantation.
Biol Blood Marrow Transplant;
25(3): 480-487, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30423481
8.
Total Body Irradiation Is Safe and Similarly Effective as Chemotherapy-Only Conditioning in Autologous Stem Cell Transplantation for Mantle Cell Lymphoma.
Biol Blood Marrow Transplant;
24(2): 282-287, 2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29061536
9.
Circulating Plasma Cells at the Time of Collection of Autologous PBSC for Transplant in Multiple Myeloma Patients is a Negative Prognostic Factor Even in the Age of Post-Transplant Maintenance Therapy.
Biol Blood Marrow Transplant;
24(7): 1386-1391, 2018 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29481870
10.
Tandem Autologous Hematopoietic Cell Transplantation for Patients with Primary Progressive or Recurrent Hodgkin Lymphoma: A SWOG and Blood and Marrow Transplant Clinical Trials Network Phase II Trial (SWOG S0410/BMT CTN 0703).
Biol Blood Marrow Transplant;
24(4): 700-707, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29289757
11.
Results from Two Consecutive Studies of Consolidation Therapy after Autologous Transplant for Multiple Myeloma: Thalidomide, Dexamethasone, and Clarithromycin or Lenalidomide, Dexamethasone, and Clarithromycin.
Acta Haematol;
137(3): 123-131, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28355602
12.
Comorbidities, Alcohol Use Disorder, and Age Predict Outcomes after Autologous Hematopoietic Cell Transplantation for Lymphoma.
Biol Blood Marrow Transplant;
22(9): 1582-1587, 2016 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-27311969
13.
Pretransplantation Minimal Residual Disease Predicts Survival in Patients with Mantle Cell Lymphoma Undergoing Autologous Stem Cell Transplantation in Complete Remission.
Biol Blood Marrow Transplant;
22(2): 380-385, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26348890
14.
New cancers after autotransplantations for multiple myeloma.
Biol Blood Marrow Transplant;
21(4): 738-45, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25555448
15.
Impact of Pretransplantation (18)F-fluorodeoxy Glucose-Positron Emission Tomography Status on Outcomes after Allogeneic Hematopoietic Cell Transplantation for Non-Hodgkin Lymphoma.
Biol Blood Marrow Transplant;
21(9): 1605-11, 2015 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-25983043
16.
Reduced-Intensity Allografting as First Transplantation Approach in Relapsed/Refractory Grades One and Two Follicular Lymphoma Provides Improved Outcomes in Long-Term Survivors.
Biol Blood Marrow Transplant;
21(12): 2091-2099, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26253007
17.
High-dose CD20-targeted radioimmunotherapy-based autologous transplantation improves outcomes for persistent mantle cell lymphoma.
Br J Haematol;
171(5): 788-97, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26455717
18.
Hematopoietic cell transplant comorbidity index is predictive of survival after autologous hematopoietic cell transplantation in multiple myeloma.
Biol Blood Marrow Transplant;
20(3): 402-408.e1, 2014 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-24342394
19.
Older patients with myeloma derive similar benefit from autologous transplantation.
Biol Blood Marrow Transplant;
20(11): 1796-803, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-25046833
20.
Outcomes of hematopoietic cell transplantation for diffuse large B cell lymphoma transformed from follicular lymphoma.
Biol Blood Marrow Transplant;
20(7): 951-9, 2014 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-24641828